Related content

Cytohesin-2 as a novel prognostic marker for hepatocellular carcinoma

By          

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2211-2218

Spandidos Publications

Access to resources Recommend Favorite

Tissue factor pathway inhibitor-2 inhibits the growth and invasion of hepatocellular carcinoma cells and is inactivated in human hepatocellular carcinoma

By                

Oncology Letters, Vol. 2, Iss. 5, 2011-01 ,pp. : 779-783

Spandidos Publications

Access to resources Recommend Favorite

Splicing factor 2/alternative splicing factor contributes to extracellular signalregulated kinase activation in hepatocellular carcinoma cells

By              

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 3890-3894

Spandidos Publications

Access to resources Recommend Favorite

Upregulation of E2F transcription factor 3 is associated with poor prognosis in hepatocellular carcinoma

By                

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1139-1146

Spandidos Publications

Access to resources Recommend Favorite

Urocortin's Inhibition of Tumor Growth and Angiogenesis in Hepatocellular Carcinoma via Corticotrophin-Releasing Factor Receptor 2

By Wang Juejin   Xu Youhua   Xu Yinyan   Zhu Huayuan   Zhang Rongjian   Zhang Guoxin   Li Shengnan  

Cancer Investigation, Vol. 26, Iss. 4, 2008-05 ,pp. : 359-368

Informa Healthcare

Access to resources Recommend Favorite